Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d65d3e9a44623b20bd8b02645a131aaa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-718 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-718 |
filingDate |
2015-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96169aa5ce22ae2a2862aa7fd9e085a9 |
publicationDate |
2016-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
MX-2015000887-A |
titleOfInvention |
FORMULATION OF BISMUTE SUBGALATE. |
abstract |
The present invention provides a bismuth subgalate formulation that can be used as a hemostatic agent in surgeries; more particularly, in otolaryngology for hemostasis after adenotonsilectomy (adenoamigdalectomy). |
priorityDate |
2015-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |